Figure 1

A survival diagram comparison of two different cytogenetic stratification methods. Using conventional stratification, three prognostic groups were distinguished based on time to first therapy (a), progression-free survival (b), and overall survival (c). When we integrated the number of cytogenetic aberrations and intratumoral subclones, the discrimination improved (d–f).